Andy Redfern is a Consultant Medical Oncologist at Fiona Stanley Hospital, a translational cancer researcher with the University of Western Australia and the current clinical head of the Cancer Division at Harry Perkins Institute. He is also Medical Director of Linear Clinical Research, WAs centre for early drug trials and is the State Lead Clinical for Breast Cancer overseeing services across the state.
Andy carried out his undergraduate Medical and Scientific training in Aberdeen, Scotland. He then trained in cancer treatment at the Royal Marsden Hospital in London; at the Northern Centre for Cancer Treatment in Newcastle-Upon-Tyne; at the Medical Oncology Centre in Auckland and at Saint Vincents Hospital in Melbourne before moving to Perth in 2001.
His research interests centre around growth signalling and mechanisms of chemotherapy and hormone therapy resistance in cancer. He has active laboratory research projects in breast cancer, prostate cancer, melanoma and bowel cancer. He is also currently conducting a variety of human trials of chemotherapies, hormone therapies and immune therapies against a range of different cancers in the clinic.
He also does work with the Cancer Council of WA, the National Breast Cancer Foundation and The Breast Cancer Network of Australia.